The biotechnology market is one of fastest emerging knowledge based sectors in India and is expected to play an important role in the rapidly growing economy of the country. On account of competitive advantages in terms of (R&D) facilities, knowledge, skills, and cost effectiveness, India has attained the reputation of the world’s most potential biotech destinations. Consequently, the market for biotechnology in the country is expected to surpass the value of INR 200 Billion by the end of fiscal 2012, says our new research report “Asia Pacific Biotechnology Market (2008-2012)”.
Further, in-depth research carried by our team of experts has revealed several reasons such as, heavy investments from global giants, focus on biosimilar along with various others, which will drive the growth of the market. Besides, the Indian biotech market has been segmented into Biopharma, Bioservices, Bioagricultural, Bioindustrial, and Bioinformatics. It has been found that the booming pharmaceutical industry has been fueling the growth of the biopharma sector, which accounts for around 61% of the total market.
Our report provides detailed profiling of biotechnology market of several fast developing countries of the Asia Pacific region such as India, China, Malaysia, Singapore, South Korea etc. The government has been identified as an important factor responsible for the growth of the industry. As a result, a detailed description of the government initiatives has been provided for each country covered in the report. Besides, a detailed description of key players of the industry has been included in the report.
Our report “Asia Pacific Biotechnology Market (2008-2012)”provides thorough analysis of the various segments of the biotech industry on the basis of products and trade together with the detailed study of the investment opportunities in various regions of the country. The report has thoroughly examined current market trends and industrial developments to enable clients understand the market structure and its progress in coming years. Due consideration has been given to the possible after effects of recession on the industry. It will help clients to have a proper insight of the current and future outlook of the India Biotech market.
For more information visit: http://www.rncos.com/Report/IM138.htm |
